Place of Publication

Cambridge, MA

Publisher

Elsevier Science and Technology

Academic Press

Publication Date

2021

Series

Proquest Ebook Central

Subjects

Immunotherapy - methods

Neoplasms - immunology

Neoplasms - therapy

ISBN

9780323857819

9780323909259

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Author

Cavalcanti, Iago Dillion Lima

Soares, José Cleberson Santos

Place of Publication

Cham, Switzerland

Publisher

Springer Nature Switzerland AG

Publication Date

2021

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Neoplasms - epidemiology

Neoplasms - immunology

Abstract

Summary:

ISBN

9783030683337

9783030683344

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer network computer. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Qazi, Asma Saleem

Tariq, Kanwal

Edition

1st ed.

Place of Publication

Cham, Switzerland

Publisher

Springer International Publishing AG

Publication Date

c2023

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Therapeutics

Drug Therapy

Hormones

Radiotherapy

Immunotherapy

Nutrition Assessment

Antineoplastic Agents

Pharmacogenomic Variants

Abstract

"This comprehensive book provides an overview of cancer therapeutics and covers different innovative treatment approaches for cancer. The initial chapter gives a detailed overview on cancer progression and disease diagnostics. The following chapters focus on different cancer treatment approaches, such as chemotherapy, radiotherapy, hormonal therapy, immunotherapy, nutritional assessments, targeted therapy and Nano therapeutics. It also highlights the importance of cancer genomics, disease advancement, personalized medicine and psychological support for cancer patients. Emphasis is also given to the many challenges in the area of designing cancer treatment and designing clinical trials. The complete book also presents cancer management with different cancer treatment modalities, including pharmacogenomics and drug reactions. This is a unique and comprehensive piece of work that not only highlights the disease treatment modalities but also focuses on many challenges in the area of designing cancer treatment and even in designing clinical trials.

The contributing authors are experts in this field of cancer treatment. By familiarizing readers with the latest developments in this complex field, the book offers a valuable resource for clinicians. Researchers and medical students will also benefit from this comprehensive text." --publisher

ISBN

9783031271557

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Amiji, Mansoor M.

Milane, Lara Scheherazade

Place of Publication

Cambridge, MA

Publisher

Elsevier Science and Technology

Academic Press

Publication Date

2021

Series

Proquest Ebook Central

Subjects

Immunotherapy - methods

Neoplasms - immunology

Neoplasms - therapy

ISBN

9780128233979

9780128236376

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Alternate Title

Cancer immunotherapy

Editor

Butterfield, Lisa H.

Kaufman, Howard L.

Marincola, Francesco M.

Edition

2nd ed.

Place of Publication

New York, NY

Publisher

Demos Medical Publishing

Publication Date

2021

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Immunotherapy - methods

Neoplasms - immunology

ISBN

9780826137425

9780826137432

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted

Author

Barbet, Jacques

Foucquier, Adrien

Thomas, Yves

Place of Publication

London, UK

Hoboken, NJ

Publisher

ISTE Ltd

John Wiley & Sons, Inc.

Publication Date

2020

Series

Proquest Ebook Central

Health engineering and society series. Health and patients set ; volume 2

Subjects

Neoplasms - therapy

Neoplasms - genetics

Immunotherapy - trends

Abstract

The combined effects of population growth and aging have led to an increase in the number of cancers. Preventing, diagnosing, treating and curing cancer are therefore, more than ever, imperatives facing medicine ? especially to continue the decrease in cancers' mortality rates and to improve the quality of survival.

Over time, the classic modes of treatment (surgery, external beam radiotherapy, chemotherapy) have become more refined and efficient. From the beginning of this century, new therapeutic options have been developed: targeted cancer therapy, targeted radionuclide therapy and immunologic therapies based on monoclonal antibodies, cellular therapy and vaccinations. Artificial intelligence and machine learning are also being introduced to the field of oncology.

Starting with the basic scientific principles relevant to oncology, this book explains and makes these concepts and innovations accessible to a wide audience ? especially in the interest of patients. It also contributes to the oncological field of 4P medicine ? with 4P standing for predictive, preventive, personalized and participative.- Provided by publisher.

ISBN

9781786304933

9781119706861

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Rezaei, Nima

Edition

2nd ed.

Place of Publication

Cham, Switzerland

Publication Date

2020

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Immunotherapy - methods

Immunomodulation

Organ Specificity

ISBN

9783030579487

9783030579494

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Alternate Title

Fast facts : immunooncology

Author

Clarke, Stephon

Li, Bob T.

Edition

2nd ed.

Place of Publication

Abingdon, UK

Publisher

S. Karger Publishers Ltd.

Publication Date

2021

Physical Description

126 p. : ill ; 21 cm.

Series

Fast facts (UK)

R2 Library

Subjects

Immunotherapy

Neoplasms - therapy

Neoplasms - immunology

ISBN

3318068217

9783318068214

9783318068221

Language

English

Material Type

Book

Ebook

Audience

Professional

Location

Abbotsford Library

Kelowna Library

Call Number

QZ267 C597 2021

Website Notes

This R2 title is licensed for unlimited BC Cancer staff users. Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Copies

Author

Hays, Priya

Edition

1st ed.

Place of Publication

Cham, Switzerland

Publisher

Springer International Publishing AG

Publication Date

c2022

Series

Proquest Ebook Central

Subjects

Hematologic Neoplasms

Neoplasms

Immunotherapy

Abstract

"This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer immunotherapies fall broadly into three categories: immune checkpoint inhibitors (ICIs), adoptive T cell therapies, and cancer vaccines which have distinct mechanisms of action. Immune checkpoint inhibitors rely upon disrupting tumor antigen recognition as self by the immune system through inhibition of checkpoint molecules. Adoptive T cell therapies involve the engineering of T cells ex vivo to target and destroy tumor cells.

The first part of this book will provide an overview of the discovery and mechanistic details of the technology. The second part will be devoted to elaborating on the clinical outcomes, successes and limitations for specific tumor subtypes, which includes both solid tumors and hematologic malignances for both pediatric and adult populations. As such, the book offers a valuable resource for oncologists, hematologists, and all those seeking an up-to-date overview of cancer immunotherapies." --publisher

ISBN

9783030963750

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Tejero, Paloma

Pinto, Hernán

Place of Publication

Boca Raton, Fla.

Publisher

CRC Press

Publication Date

2021

Series

Proquest Ebook Central

Subjects

Neoplasms - therapy

Neoplasms - psychology

Body Image - psychology

Esthetics

Antineoplastic Agents - adverse effects

Radiotherapy - adverse effects

Hair - radiation effects

Nails - radiation effects

Skin - radiation effects

Abstract

Contents:

The oncological patient and aesthetic medicine: The bonded approach -- Challenges for oncology: Prevention, palliation, and survival -- Cancer as a chronic disease -- Clinical record: Oncological screening -- Tumor markers -- The psychological approach: The healing power of image and comprehensive assistance to cancer patients -- The role of the family -- The oncological patient environment: Legal framework and ethics -- Radiotherapy: The prevention of secondary effects, radiodermatitis, and long-term toxicity -- Prevention and treatment of dermatological secondary effects of cancer therapy -- Prevention and treatment of adverse effects of antineoplastic therapy and of delayed-onset side effects: Prevention and treatment of hair loss -- Melatonin for prevention and treatment of complications associated with chemotherapy and radiotherapy: Implications for cancer stem cell differentiation -- Chronic antineoplastic therapies and their impact on quality of life -- Interactions with medical-aesthetic treatments -- Medical-aesthetic treatments in the survivor patient -- Medical-aesthetic treatments in oncology patients -- Facial medical-aesthetic treatments in oncology patients -- Filler materials: Indications, contraindications, and special considerations in oncology patients -- Aesthetic medical treatments during the disease: What is the plan? -- The role of the aesthetic doctor in follow-up of the oncology patient -- Medico-aesthetic collaboration -- Dietetics and nutrition in oncology patients: Evaluation of nutritional status, weight control, and nutrigenomics -- Nutrition: Diet therapy and nutritional supplements -- Introduction to vascular complications in oncology patients -- Anatomy of lymphatic drainage of the limbs -- Prevention and treatment of secondary lymphedema of extremities, early diagnosis of lymphostasis, and postsurgical prevention and conservative treatment of lymphedema -- Prevention and treatment of venous thromboembolism -- Cosmetic-medical treatments -- Micropigmentation applied to oncology patients -- Photoprotection in oncology patients -- Scar care after surgical treatment in oncology patients -- Cancer and physical exercise -- Ozone therapy in oncology patients -- Thermal treatments in postcancer care

ISBN

9781138305571

9781351395076

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer network computer. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Lee, Daniel W.

Shah, Nirali N.

Place of Publication

Cambridge, MA

Publisher

Elsevier, Inc.

Publication Date

2020

Physical Description

xiv, 229 p. : ill. ; 24 cm.

Subjects

Neoplasms - therapy

Receptors, Chimeric Antigen - therapeutic use

Receptors, Antigen, T-Cell

Immunotherapy, Adoptive - methods

Cell- and Tissue-Based Therapy

Abstract

Contents:

Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients receiving CAR therapy -- Neurotoxicities after CAR-T cell immunotherapy -- Hematologic and non-CRS toxicities -- Response assessment and post-CAR-T cell therapy management -- Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy -- Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas -- CAR T cell therapy for CNS malignancies -- CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.

ISBN

9780323661812

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Abbotsford Library

Victoria Library

Call Number

QZ266 C538 2020

Copies

Editor

Naing, Aung

Hajjar, Joud

Edition

3rd ed,

Place of Publication

Cham, Switzerland

Publisher

Springer Nature Switzerland AG

Publication Date

2020

Series

Proquest Ebook Central

Advances in experimental medicine and biology

Subjects

Immunotherapy

ISBN

9783030410070

9783030410087

ISSN

0065-2598

2214-8019

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Chu, Edward

DeVita Jr., Vincent T.

Edition

22nd ed.

Place of Publication

Burlington, MA

Publisher

Jones & Bartlett Learning

Publication Date

c2023

Series

Proquest Ebook Central

Subjects

Drug Therapy

Pharmacology, Clinical

Neoplasms--drug therapy

Abstract

"Written by world-class experts in clinical cancer therapeutics, Physicians' Cancer Chemotherapy Drug Manual 2022 provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens--both on- and off-label--for the treatment of all the major cancers."--publisher

ISBN

9781284229653

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Olsen, MiKaela

Edition

2nd

Place of Publication

Pittsburgh, PA

Publisher

Oncology Nursing Society

Publication Date

2024

Series

Proquest Ebook Central

Subjects

Chemotherapy

Drug Therapy

Immunotherapy

Neoplasms - nursing

Neoplasms - therapy

Neoplasms - drug therapy

Antineoplastic Agents - administration & dosage

Antineoplastic Agents - adverse effects

Nurses' Instruction

Practice Guideline

ISBN

9781635930559

9781635930566

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Russo, Antonio

Maurea, Nicola

Farmakis, Dimitrios

Giordano, Antonio

Place of Publication

Cham, Switzerland

Publisher

Springer

Publication Date

2022

Series

Proquest Ebook Central

Current clinical pathology

Subjects

Cardiotoxicity - complications

Neoplasms - complications

Immunotherapy - adverse effects

ISBN

9783030977436

9783030977443

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer network computer. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Ghobadi, Armin

DiPersio, John F.

Edition

1st ed.

Place of Publication

Cham, Switzerland

Publisher

Humana Press

Publication Date

c2022

Series

Proquest Ebook Central

Subjects

Immunotherapy, Adoptive

Lymphoma

Leukemia

Lymphocytes, Tumor-Infiltrating

Abstract

"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia (ALL). These advances have dramatically improved the management of patients with relapsed refractory lymphoma, myeloma and leukemia. Gene and Cellular Immunotherapy for Cancer offers readers a comprehensive review of current cellular and gene-based immunotherapies. Divided into eighteen cohesive chapters, this book provides an in-depth and detailed look into cellular-based immunotherapies including CAR-T, TCR-T, TIL, Viral CTLs, NK cells in addition to T/NK cell engagers, focusing on their historical perspectives, biology, development and manufacturing, toxicities and more.

Edited by two leading experts on gene and cellular immunotherapy, the book will feature chapters written by a diverse collection of recognized and up-and-coming experts and researchers in the field, providing oncologists, immunologists, researchers and clinical and basic science trainees with a bench to bedside view of the latest developments in the field." --publisher

ISBN

9783030878481

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Chu, Edward

DeVita, Vincent T., Jr.

Edition

23rd ed.

Place of Publication

Burlington, MA

Publisher

Jones & Bartlett Learning, LLC

Publication Date

2023

Series

R2 Library

Subjects

Antineoplastic Agents

Neoplasms - drug therapy

Handbook

Abstract

"Completely revised and updated for 2023, the Physicians' Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens-both on- and off-label-for the treatment of all the major cancers." -- Provided by publisher

ISBN

1284272737

9781284272734

9781284272741

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This R2 title is licensed for one BC Cancer staff user at a time only. Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Strauss,Bernhard

Bertolaso, Marta

Ernberg, Ingemar

Bissell, Mina J.

Place of Publication

Cambridge, MA

Publisher

MIT Press

Publication Date

2021

Series

Proquest Ebook Central

Vienna series in theoretical biology

Subjects

Neoplasms - genetics

Neoplasms - therapy

Abstract

Summary:

"Steps toward an explanatory paradigm for cancer that integrates its different levels of organization (molecular, genetic, etc.) and also integrates theoretical and experimental biology with oncology"-- Provided by publisher.

ISBN

9780262045216

9780262362085

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Editor

Malviya, Rishabha

Singh, Arun Kumar

Yadav, Deepika

Edition

1st ed.

Place of Publication

Beverly, MA

Publisher

Scrivener Publishing

Publication Date

c2023

Series

Proquest Ebook Central

Subjects

Chemotherapy

Drug Resistance, Neoplasm

Abstract

"The book details the mechanisms underlying multi-drug cellular resistance and the targets of novel chemotherapeutic agents.

Cancer is a major killer all over the world. Even with all the progress made, chemotherapy is still the mainstay of modern cancer treatment. The progression of the cellular defeat of numerous independent anticancer drugs in terms of their chemical structure is a major barrier to successful chemotherapy. Multi-drug resistance (MDR) is a term for the fact that most cancer patients exhibit this phenomenon. According to the numbers, drug resistance carries the blame for 90% of cancer patient deaths. Refractory cancer and tumor recurrence are common outcomes of prolonged chemotherapy. Because of the prevalence of drug-resistance mutations, the difficulty of treating tumors increases and the therapeutic efficacy of drugs decreases.

Multi-Drug Resistance in Cancer: Mechanism and Treatment Strategies contains nine chapters that cover topics such as: studying the mechanics of resistance to drugs by autophagy; studies to delineate the role of efflux transporters; expression of drug transporters; resistance to targeted therapies in breast cancer; advances in metallodrug driven combination treatment for cancer; and use of natural agents for the overcoming of cancer drug resistance.

The book aims to provide the latest data on the mechanisms of cellular resistance to anticancer agents currently used in clinical treatment. It provides a better understanding of the mechanisms of MDR and targets of novel chemotherapy agents which should guide future research concerning new effective strategies in cancer treatment.

Audience

This book is written for pharmaceutical and biomedical scientists and researchers at both the bench and in the clinic who are interested in the mechanisms and strategies for overcoming cancer's multi-drug resistance." --publisher

ISBN

9781394209217

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This title is licensed for one user at a time on BC Cancer-network computers. If you are denied access while on a network computer, try again later.

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Author

Chu, Edward

DeVita, Vincent T., Jr.

Edition

21st ed.

Place of Publication

Burlington, MA

Publisher

Jones and Bartlett Learning

Publication Date

2022

Series

R2 Library

Subjects

Neoplasms - drug therapy

Antineoplastic Agents - therapeutic use

ISBN

1284230139

9781284230130

9781284230284

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This R2 title is licensed for one BC Cancer staff user at a time only. Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.